President Trump is reportedly pushing for higher blanket tariffs on imports from the European Union, throwing a wrench in negotiations ahead of an Aug. 1 deadline for sweeping duties to take effect.

President Trump and his administration have been studying new sectoral tariffs that could cover a broad part of the American ...

Despite former President Donald Trump’s threat of a 200% tariff on imported drugs during a cabinet meeting, pharmaceutical investors have shown surprisingly positive sentiment this week. Despite ...

The opening salvo of second-quarter earnings calls this week came against President Donald Trump’s renewed calls for a tariff ...

As Washington presses ahead with additional tariffs on products from the European Union (EU) and beyond, European officials ...

President Donald Trump's proposed tariffs on pharmaceuticals could lead to higher prices, higher insurance premiums, and even drug shortages, experts say.

Novartis ( NYSE: NVS) CEO Vas Narasimhan said the company has built up its U.S. inventories to help mitigate the impact of ...

The United States recent tariff announcements have cut down forecast for Southeast Asian economies, with the more ...

Bank of Ireland has revised upwards its economic forecasts for the year - if US tariffs remain at 10%. It predicts GDP growth of 8.1%, higher than the 3.5% growth previously forecast. The bank says ...

Key Points Adjusted EPS reached $2.77 in Q2, topping estimates by $0.09, but fell year over year. Revenue rose 5.8% year over year to $23.7 billion, exceeding estimates by $889 million. Full-year 2025 ...

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.

The White House’s decision to safeguard $400m in President’s Emergency Plan for AIDS Relief (PEPFAR) funding to support the global human immunodeficiency virus (HIV) emergency provides “hope” to ...